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ABSTRACT
Quantum dots (QDs), which are intensely fluorescent nanocrystals ranging 2-10 nanometers in
diameter, have shown promise in fluorescence imaging. However, in vivo applications of QDs
are limited due to the opaque surrounding of tissue and bones. In this study, InP/ZnS QDs were
doped with a paramagnetic atom in an attempt to render them MRI-active. We have further
bioconjugated these nanoprobes to develop highly specific MRI-active probes that can be used
for detection of neurodegenerative diseases. These bioconjugated nanoprobes detect a mutated
form of alpha-synuclein that forms oligomers that are a hallmark of Parkinson’s disease and
other alpha-synucleinopathies. Here, we have optimized the doping of QDs with MRI-active
metals (e.g. Gadolinium) and characterized the MRI activity. The resulting nanocrystals were
further studied to assess the success of the paramagnetic atom’s incorporation into the crystal
lattice and its performance as a probe for alpha-synucleinopathies such as Parkinson’s disease.
KEYWORDS: quantum dots, magnetic resonance imaging, nanoparticles, bioconjugation,
synthesis
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CHAPTER 1: INTRODUCTION

1.1 Quantum Dots
Quantum dots (QDs) are highly fluorescent semiconductor nanocrystals that have sizedependent optical properties. QDs are typically about 2-10 nm in diameter and composed of
anywhere from hundreds to thousands of atoms 1,2,3,4. QDs composed of group II-VI elements
(e.g., CdS or CdSe) had been popular for use in biomedical research; however, studies have
shown that Cd-based QDs can be degraded in a biological environment, leading to release of
cytotoxic Cd2+ ions4. For this reason, researchers investigated alternative QDs with a more
biologically compatible core, composed of group III-V elements (i.e. InP)3. Compared to
conventional organic dyes, QDs are resistant to photobleaching, giving them the potential to be
used long-term1. Additionally, they can be easily biofunctionalized for applications in
biomedical research, diagnostics, and therapeutics 4,5.
QDs exhibit size-dependent optical properties, such as absorbance and
photoluminescence, that fall in between a bulk semiconductor and discrete molecule 6,7. The
physical radius of a QD is smaller than the material’s Bohr radius, which is described as the
separation between an excited electron in the conduction band and the hole it leaves in the
valence band8. The confinement of electrons into a quantum box causes a conversion from
continuous to discrete energy levels. For QDs with a smaller size, the difference in energy
between valence and conduction bands is much larger, requiring more energy for excitation, but
also releasing more energy as the electron returns to the ground state. As the size of the QD
increases, the band gap decreases resulting in a red-shift (Figure 1)9. Because of this, the relative
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size distribution in QDs can be observed as the full-width half maximum in a fluorescence
emission spectrum.

Figure 1: Band gap energy and emission of QDs 10. The band gap of a respective QD has an
inverse relationship with size, due to quantum confinement. The larger the size, the smaller the
band gap and energy.
During fluorescence, an excited electron can proceed through two different relaxation
processes: radiative and non-radiative decay (Figure 2). In radiative decay, light is emitted as a
result of relaxation. In the case of non-radiative decay, however, energy is released instead as
heat, and electrons move from a high energy level to a meta-stable level6,7. Defects on the QD,
also known as surface traps, act as sites for nonradiative decay. Some of the excited electrons can
decay to these surface traps located mid band gap. They then nonradiatively recombine with the
holes located in the valence band, reducing photoluminescence quantum yield 8. Placing an
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inorganic shell with a large bandgap over the QD core (sometimes referred to as “shelling”) can
help to passivate these defects and improve fluorescence as well as photostability1.

Figure 2: Jablonski energy diagram11. The Jablonski diagram shows different paths of relaxation
an electron can proceed through after reaching an excited state.
InP nanocrystals are prone to surface oxidation and photodegradation, and ultimately,
poor fluorescence. To mitigate this, the InP core is often shelled as mentioned above, promoting
stability and increasing photoluminescence5. In a Type I (e.g. InP/ZnS) core/shell composition,
the conduction band of the shell is at a higher energy than the core, while the valence band is at a
lower energy than that of the core, effectively confining both the electrons and their holes to the
core (Figure 3)1,12. This has been shown to increase photoluminescence quantum yield by
3

reducing nonradiative recombination12. In deciding on a core and shell, the materials must have
analogous crystal structure with lattice mismatch below a threshold to feasibly allow for shell
growth (~12%)13. ZnS in advantageous as a coating material for InP QD cores since the lattice
mismatch is only 7.6% and it is chemically stable and nontoxic12,13.

Figure 3: Core/Shell bandgap distribution12. (a) In a Type I core/shell structure, the band gap of
the shell material, pictured on either side of the core, confines both the electron and its hole to
the core. (b) Positions of both valence and conduction bands for various semiconductor
materials. ZnS’s band gap easily confines that of InP.
1.2 Synthesis
There are several methods for synthesizing QDs, but most relevant method for this work
is hot-injection, where precursors are injected into the heated reaction mixture during synthesis 14.
Before the reaction is started, precursors for indium and zinc are added to a coordinating solvent,
the temperature is increased, and an inert atmosphere is introduced. Addition of the phosphorous
precursor initiates the crystallization of the QDs, which can be broken up into three stages:
precursor conversion, nucleation, and growth. All three steps occur in rapid succession, making
the study of the kinetics of crystallization difficult16.
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In the first step, called precursor conversion, phosphine and indium species present in the
reaction mixture interact to form InP monomers (Figure 4). One of the prevailing theories

Figure 417: InP formation. (Scheme 1) InCl3 forms an adduct with the aminophosphine with a
delocalized positive charge, allowing for (Scheme 2) a nucleophilic attack by a second
aminophosphine group leading to an InP intermediate and phosphonium salt. (Scheme 3) Two
more equivalents of the aminophosphine further reduce the phosphorous of the intermediate to
an oxidation state of -III, forming InP.
postulates that formation of InP from InCl3 and tris(dimethylamino)phosphine (TDMAP) is
dependent on the type of coordinating solvent used17. In order for the reaction to take place, the
coordinating solvent must have a primary amine, such as oleylamine17. This allows TDMAP to
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undergo transamination, a nucleophilic attack from the phosphorous center of one TDMAP on
the amino group of another. The resulting fully transaminated product then proceeds as a
reactant. In order for this reaction to proceed, there must be ~4 times as much TDMAP as there
is InCl3; 3 equivalents of transaminated aminophosphine reduce a fourth in order to form the InP
monomer through oxidation and reduction17.
Following the precursor conversion to InP, nucleation and growth occur. Classically,
nucleation and growth are described using LaMer’s model that separates nucleation and growth
into two steps, which is essential for synthesizing monodisperse nanocrystals (NCs). In this
model, a rapid burst of nucleation occurs directly followed by the growth stage 16. Here, this is
achieved using hot-injection of a phosphorous precursor to trigger monomer formation, followed
by a burst of nucleation. As nuclei form, the monomer concentration decreases, and NCs move
into the growth stage18. During growth, NC size can increase when smaller NCs dissolve, a
process called Ostwald ripening16. This effect can lead to a larger size distribution of NCs.
Once core growth is terminated, shelling can be initiated. Previous work has suggested
that oleylamine ligands and the zinc precursor species passivate the surface of the InP cores,
providing a Zn-rich surface for growing ZnS shells (Figure 5)18. Shell formation is initiated by
addition of a sulfur precursor (e.g. dodecanethiol). Additional shelling is facilitated by the
addition of more zinc precursor, which improve photostability and quantum yield 20. During
shelling, dodecanethiol binds with the ZnS on the surface, becoming the surface capping ligand
for the final core/shell QD product18.
For QDs to be biologically relevant, they must be water-soluble, which requires
exchanging the existing surface ligands for water-soluble ligands. 11-mercaptaundecanoic acid is
often used as a water-soluble surface ligand due to its facile exchange and binding energy21. The
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Zn-Sthiolate binding energy (194.7 kJ/mol) is higher in comparison to both a S-Sthiolate and Zn-Sthiol
with binding energies of 105.1 kJ/mol and 31.8 kJ/mol, respectively22. Tetramethylammonium
hydroxide (TMAH) is used as a base to deprotonate the thiol of MUA. The deprotonated MUA
forms ion pairs with tetramethylammonium cations, allowing it to be transferred into the
chloroform solvent. This gives rise to the bond between the thiolate and ZnS surface, allowing
the QDs to ultimately be transferred to the aqueous phase21.

Figure 5: Surface passivation of InP cores19. Leading up to shell formation, oleylamine ligands
and zinc stearate passivate the surface of the cores.
1.3 QD Doping
One way to impart optical, magnetic, electrical, and electronic properties to QDs is by
doping the structure with an impurity. Impurity states introduced by a dopant allow for high

7

quantum yield emissions and have been documented to cause a red-shift in emission, possibly
due to dopant d-d levels or interaction of the dopant d level with the core material23. Examples
have included Cu and Mn, with the latter showing a marked improvement in quantum yield 23,24.
Doping of QDs can be performed either extrinsically or intrinsically. Extrinsic doping is
characterized by two types: charge injection methods or the use of certain surface ligands to
induce further functionality of QDs24. Intrinsic doping involves doping the core of the QD by
nucleation, growth doping, or ion diffusion24,25. In the ion diffusion method, the dopant precursor
is incorporated into the reaction mixture prior to nucleation or growth. Ion diffusion can
separately be broken down into cation exchange for diffusion doping 23. In this work, doping is
used to introduce Gd3+ as a core dopant using intrinsic methods.

Figure 6: QD phase transfer21. InP/ZnS QDs shown on the left are in organic solvent (bottom
phase) with dodecanethiol surface ligands. On the right, QDs transfer to the upper aqueous phase
with MUA surface ligands.
1.4 Magnetic Properties
The desired properties of the QD determines the choice of dopant. Magnetic functionality
has been of recent interest for its potential in multimodal imaging 26,27. By imparting magnetic
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properties to QDs, they could be used to provide contrast in magnetic resonance imaging (MRI),
a method critical for clinical diagnostics in disease and injury26. Manganese (Mn2+) and
Gadolinium (Gd3+) are the most common paramagnetic ions used as contrast agents for MRI. For
this reason, they are being investigated for incorporation into QD structures 26. By doping QDs
with a paramagnetic ion, relaxivity per QD is larger than it would be per ion due to the ability for
each QD to host many paramagnetic ions1,27. This characteristic is useful for magnetic probes
with a molecular target.
The magnetic properties of a paramagnetic ion are of particular interest for use in nuclear
magnetic resonance (NMR). In a paramagnetic ion, there is a minimum of one unpaired electron,
behaving as a tiny magnet. In the presence of a strong external magnetic field (B 0), nuclear spins
can adopt either a parallel or antiparallel orientation in relation to the external field (Figure 7);
the nuclear spin represents the total angular momentum of a nucleus and is associated with a
magnetic moment28,29. Of the two orientations, parallel alignment occurs as the lower energy
state, making it the preferred alignment, though the energy difference between the states is
relatively small29. This difference, however, results in a net magnetization vector (Mz) aligned to
the magnet. Individual nuclei do not line up with the field but wobble, or precess, around the
direction of the magnetic field at a frequency described by the Larmor equation28.
In order to gain information regarding the nuclear spin, the direction of the net
magnetization factor (Mz) must be changed to give a measurable signal. This is done by exciting
the spins using radiofrequency (RF) pulses28,29. The energy from the RF pulse is absorbed by
protons, thus allowing them to go from a parallel state to antiparallel. The spins then precess in
phase, and Mz align 90 into the transverse plane. When the RF transmitter is off, nuclei return
to their ground state, magnetization in the transverse plane decreases, and the induced signal
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decreases, referred to as free induction decay (FID). The time it takes for the signal to return to
equilibrium is the relaxation time28.

Figure 7: Effect of magnetic field on nuclear spin28. Without a magnetic field, magnetic moments
have random distribution. With the application of a strong external magnetic field, spins align in
an antiparallel or parallel fashion. The net magnetization vector (Mz) runs parallel with B 0.
Relaxation can be described with two different constants: T1 (longitudinal) and T2
(transverse). T1 is characterized by realignment with B0 toward a spin’s thermal equilibrium
value. T2, however, is characterized by the decay of coherence: after an RF pulse, spins are in
phase, but as time passes, the signal decreases as spins begin to dephase from inhomogeneities or
spin-spin interaction. The T2 time is always shorter than T1. Signals from these measurements
can be converted using Fourier transform to corresponding intensity, which is pixel mapped into
shades of gray in an image (Figure 8)28,29.
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Generating data for T1 and T2 times require different methods of data collection.
Repetition time (TR) refers to the length of time between RF pulses applied to a sample. Time to
Echo (TE) measures the time between the RF pulse and the echo signal. In general for T 1, short
TE and TR times are used, while T2 images are produced with longer TE and TR times28,29.

Figure 8: T1 vs T2 weighted images30. Notable differences between T1 and T2 images in the brain
are shown here. T1-weighted images show the cerebral spinal fluid (CSF) dark. In a T2 weighted
image, however, CSF is bright with higher pixel intensity.
1.5 Biomedical Application
Parkinson’s disease (PD) is a neuromuscular disease characterized by the degeneration of
dopaminergic neurons in the substantia nigra region of the brain. Usually by the time a patient
starts presenting with motor impairment, >50% of dopaminergic neurons and up to 80% of
synaptic activity are lost in this region, taking place over years preceding diagnosis 31. The
disease is often able to progress quite far before therapeutic intervention due to difficulties in
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diagnosing PD and problems with patients self-reporting symptoms. Currently, to diagnose a
patient with PD, a doctor must take a patient history and consider the symptoms reported by the
patient. Because this decision is largely based on patient self-reporting, there is potential for
inaccuracies. No definitive test exists at this time to diagnose a living patient, since PD can only
be confirmed on autopsy with microscopic observation of the affected neurons 31,32.
One possible target for developing a diagnosis method lies with a defining trait of PD.
The hallmark of PD is the presence of Lewy bodies, structures in the cytoplasm of neurons that
contain aggregates of misfolded protein alpha-synuclein32,33. Alpha-synuclein is a 140-residue
protein that has been shown to aggregate, or oligomerize, in disease states, interfering with
neuron signaling33. Previous work in our lab has established a method by which QDs can be
bioconjugated to a peptide that binds to toxic alpha-synuclein oligomers. Coupling this peptidebinding detection method with Gd-doped QDs could allow for the development of an MRI-based
method to detect and observe the progression of PD.

1.6 Assessing QD Toxicity
Before Gd-doped QDs can be used in biological applications, a toxicity assay should be
performed to determine the effects of the presence of Gd in the Gd:InP/ZnS QDs. One way to
determine toxicity of nanoparticles or drugs on cells is through a colorimetric assay based on 3[4,5-dimethylthizol-2-yl]-2,5 biphenyl tetrazolium bromide (MTT)34. Since most viable cells
have constant mitochondrial activity, cellular viability can be measured by the activity of
succinate dehydrogenase, a crucial mitochondrial enzyme. When MTT is in the presence of
active succinate dehydrogenase, it is reduced to MTT-formazan, which is a purple crystal. Once
MTT-formazan has formed inside the cells, the cells can be lysed using a detergent. The crystals
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then are solubilized, and the formazan quantified via absorbance at 570 nm. An increase or
decrease in formazan concentration depicts increased or decreased mitochondrial activity (i.e.
cellular viability)35. In order to generate a standard curve to quantitate viability, cells are plated
at concentrations appropriate to the cell line and are dependent upon rate of proliferation and
mitochondrial activity; here, the cell were plated at 500 – 2,750 cells per well. Plating at too high
of a cell density can lead to a plateau in cell growth from contact inhibition, exhaustion of cell
medium, and exceeding maximal OD value for measurement. In order to assess the effect of a
QD sample on cell viability, a range of QD concentrations replicating that usually used for cell
treatment is selected. After plating cells at a concentration that falls in the range of the standard
curve, cells are allowed to proliferate for 24 hours before being treated in triplicate with QDs for
an additional 24 hours. After this, each well is treated as previously described with MTT and
subsequently a detergent. The measured absorbance of the lysed QD-treated cells is compared
against the lysed control cells (not treated with QDs) to determine the percent cell viability34,35.
In InP/ZnS QDs, known for their decreased toxicity, were doped with Gd. The amount of
Gd used in the initial reaction for core nucleation growth was varied to determine how much Gd
was incorporated into the nanocrystal, and how this affected the relaxation time of the QD.
Additionally, one QD synthesis was performed to attempt to incorporate Gd into the shell of the
QD to see if the closer proximity of Gd to the surface (and thus nearby water molecules) would
increase relaxation in comparison to core doping. Post-synthesis characterization by UV-Vis
spectroscopy and fluorimetry was used to determine the optical properties and size distribution
of each QD sample. Scanning Transmission Electron Microscopy (STEM) was performed to
determine whether Gd had an effect on size or size distribution. To determine the success of
doping, Inductively Coupled Plasma (ICP) spectroscopy was used to obtain molar ratios of
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elements present in QDs and assess the amount of Gd incorporated into the QD. Further studies
were done investigating the relaxation potential of samples and cell viability to determine the
effect these QDs would have at similar concentrations to those seen in normal cell targeting
studies. From this work, properties such as monodispersity, NMR relaxation potential, and
cytotoxicity determine whether Gd:InP/ZnS QDs are indeed feasible as a diagnostic tool.
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CHAPTER 2: EXPERIMENTAL

2.1 Reagents
All chemicals were purchased from Millipore Sigma (St. Louis, MO) except for the
following: InCl3 99.995% (193190100, Acros Organics), GdCl3 anhydrous (93-6416, Strem),
200 proof ethyl alcohol (200-CSPTP, Ultrapure), Sodium phosphate dibasic anhydrous (BP332500, FisherBiotech), 1-dodecanethiol (117625000, Acros Organics), methanol (A434-20, Fisher
Chemical), and sodium dodecyl sulfate (SDS) (61-1043, BioPhore).

2.2 Core/Shell QD Synthesis
Prior to synthesis, all glassware was cleaned in a base bath of 8% KOH in 3:1 EtOH:H2O.
The synthesis method used here was an adaptation from previous work36. 0.903 mmol InCl3 and
1.83 mmol Zn stearate was added to a 100 mL round bottom flask (RBF) containing 30 mL
oleylamine and a stir bar. The RBF was placed in a heating mantle over a stir plate and
connected to a proportional-integral-derivative (PID) temperature controller with temperature
probe. The mixture was stirred, and the RBF was placed under a vacuum for 1 hour, then the
temperature was increased to 120C and the RBF was evacuated further for 20 minutes. The
RBF was then filled with argon gas and the temperature raised to 230C and allowed to stabilize
for 15 minutes. To initiate core nucleation and growth, 1 mL tris(dimethylamino)phosphine was
quickly injected. After 9.5 minutes, the reaction was removed from heat and allowed to cool to
200C to terminate core formation. The temperature was then increased to 240C and 6 mL
dodecanethiol was slowly added to the reaction mixture to begin passivation of the QD cores
with a ZnS shell. After 3 hours, an additional 1.85 mmol Zn stearate (dispersed in 10 mL
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oleylamine) was slowly injected. The reaction was allowed to proceed for 3 more hours, then
cooled to 60C, and 10 mL of hexanes added. The resulting solution was then transferred to a 50
mL centrifuge tube and centrifuged at 3,000 x g for 10 minutes. To wash the QDs and remove
excess organic ligands, the supernatant was separated into two 50 mL centrifuge tubes, 70%
methanol: 30% chloroform was added to bring the total solution to 50 mL, and the solution was
centrifuged again at 3,000 x g for 10 minutes. The resulting pellet was then redissolved in 10 mL
chloroform and the washing step repeated two more times. QD samples were stored at -20C.
For core doped QDs, in the initial reaction vessel, either 0.224 mmol, 0.336 mmol, or 0.336
mmol GdCl3 was added to the original InCl3, Zn stearate, and oleylamine mixture before the
reaction started. In the case of the shell doped sample, 0.224 mmol GdCl3 was suspended in 6
mL dodecanethiol and slowly injected during shelling.

2.3 UV-Vis Spectroscopy
For UV-Vis spectroscopy, stock solutions of all samples were diluted 10-fold, with the
exception of the shell-doped QDs, which were diluted 2-fold to preserve the signal-to-noise ratio
in the spectra. QD samples were placed in a 60 L cuvette (path length of 0.3 cm) and scanned at
a rate of 51 nm/min from 750 nm to 300 nm. For analysis of the data (particle size and
concentration), calculations were used from literature on InP/ZnS QD kinetics 37. To determine
the stock concentration, the maximum wavelength and absorbance of the shoulder peak was
used. To first determine particle size the following equation was used:

𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑠𝑖𝑧𝑒 = 0.1456𝑒 (0.0052 × )
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where  is the maximum wavelength of the shoulder peak. The extinction coefficient was then
calculated using:


106

= 0.0092(𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑠𝑖𝑧𝑒)3.959

From here, Beer’s law was used to calculate the concentration of the solution:

𝐴 = 𝜀𝐿𝑐

where L is the path length of the cuvette, A is the absorbance at the maximum wavelength, c is
concentration in units, and  is the previously calculated extinction coefficient.

2.4 Fluorescence Spectroscopy
To perform fluorescence spectroscopy, all samples were diluted to 1 M and the cuvette
rinsed with chloroform between each sample. Emission spectra were collected using an
excitation wavelength of 250 nm and data collected from 400-800 nm, covering the visible
range. All slit widths were set to 5 nm and the step size and integration set to 1 nm and 1 sec
respectively to reduce the signal to noise ratio and make it easier to elucidate all spectral
characteristics.

2.5 QD Water Solubilization
Prior to ligand exchange, the QDs were washed again by adding 15 mL degassed ethanol
to 5 mL QDs (a ratio of 3:1) and centrifuging at 3,000 x g for 5 minutes. The pellet was
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resuspended in degassed chloroform, and the wash step repeated once more. 12.5 mmol
tetramethylammonium hydroxide (TMAH) was dissolved in 25 mL of DI water to make a 0.5 M
solution. 12.5 mmol of 11-mercaptoundecanoic acid (MUA) was then dissolved in this TMAH
solution to make a final solution consisting of 0.5 M TMAH and 0.5 M MUA. Equal volumes of
QDs in chloroform and 0.5 M TMAH/MUA were combined and stirred vigorously to create an
emulsion for 12-24 hours.
The solution was then centrifuged at 3,000 x g for 5 minutes to separate the organic and
aqueous layers. The aqueous layer (top) was collected and the organic layer (bottom) was
discarded, and the aqueous layer was further centrifuged at 17,000 x g to ensure full separation
from organics. To purify the QDs, they were dialyzed for 4 days in 300 kD MWCO dialysis units
against 4L 0.01 M phosphate buffer (pH 11.5) with frequent replacement of the buffer. The
resulting samples were then filtered through a 0.22-micron filter in a 1 mL syringe to remove
aggregates. Water soluble QDs were stored at 4C.

2.6 Scanning Transmission Electron Microscopy (STEM)
A 10 L volume of QD solution was pipetted onto ultrathin carbon on lacey carbon
coated copper TEM grids (Tedpella PN: 01824). After 2 minutes of settling time, the excess
solution was wicked away and the remaining volume was left to evaporate in a vacuum
desiccator. The TEM grids were then imaged with a scanning transmission electron microscopy
(STEM) detector on a thermal field emission scanning electron microscope (FESEM). Imaging
was done with a KE Developments STEM detector in bright field mode on a JEOL 7600F
FESEM at 30 kV acceleration voltage.
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2.7 ICP/MS
For QD sample preparation, approximately1 mg of each sample was dissolved in 1 mL of
nitric acid and sonicated, and then an internal standard stock (ISS) was added to a final
concentration of 5 L/mL. Each sample was then diluted to 10 mL with DDI water and nitric
acid to a final concentration of 20% nitric acid. To create standard curves for each element,
concentrations of 5,000, 10,000, and 50,000 ppb were used for P, S, Zn, and In; for Gd, 500,
1,000, and 5,000 ppb standards were used. In the method used, P-31, S-34, and Zn-66 were
monitored with Sc-45 as the internal standard (IS), In-255 with Cd-111 as the IS, and Gd-157
with La-139 as the IS. Each sample was run with a 60 sec uptake, 40 sec sample stabilization, 10
sec water rinse, 10 sec acid rinse, and 20 sec probe rinse through 1.05 L/min nebulizer argon
flow and a 1550 W plasma. The integration for all masses was 0.50 s.

2.8 Cell Culture
All cell culture reagents were purchased from HyClone (Logan, UT) except the
following: Fetal bovine serum (35-010-CV, Gibco), 0.25% Trypsin-EDTA (25200-056, Gibco),
Sodium Pyruvate (11360-070, Gibco), FluoroBrite™ DMEM (A18967-01, Gibco), and 96 well
plates (353072, Falcon). N2a (mouse neuroblastoma) cells were a kind gift provided by Dr.
Tania Q Vu at Oregon Health and Science University.
In order to sustain the cell line, N2a cells were grown and split once every 2-3 days to
maintain a suitable environment for healthy cells. When cells reached about 80% confluency,
they were passaged using sterile technique in a biosafety cabinet. The media was aspirated from
the cells, phosphate buffered saline (PBS) was added to wash away any excess media and
aspirated away, and then trypsin added and the flask returned to the incubator for 4 minutes to
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allow cells to detach from the surface of the flask. After this time, 3 mL DMEM was added and
then mixture removed and placed in a 15 mL falcon tube. Here the mixture was then pipetted up
and down to deaggregate cells before adding 0.5 mL of cells a new flask containing 5 mL of
DMEM. Cells were returned to the incubator to incubate at 37C and 5% CO2.

2.9 MTT Cell Viability Assay
To generate a standard curve, N2a cells were plated into 96 well plates at 2,750, 2,500,
2,250, 2,000, 1,750, 1,500, 1,250, 1,000, 750, 500, and 250 cells/well in triplicate. For each QD
treatment, 1,500 cells/well were plated in triplicate. The plate was incubated at 37C and 5%
CO2 for 24 hours. To assess the toxicity of the QDs on N2a cells, 6 concentrations ranging from
250 pM - 500 nM of QDs were diluted with PBS. After the cells had incubated for 24 hours, a
control of PBS and all 6 QD dilutions were applied in triplicate and the plates placed back in the
incubator for another 24 hour period. Media was then replaced with 50 L FluoroBrite™
DMEM media and 50 L 0.5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) in PBS and the cells were incubated for 3 hours to allow for formazan crystal
formation. To lyse cells and solubilize the crystals, an additional 150 L 10% SDS solution was
added to each well and the cells were allowed to incubate for 30 minutes. The absorbance of
each solution in the wells was then measured at 570 nm.

2.10 Magnetic Resonance Image Acquisition
MRI data were acquired on a 21.1 T (900 MHz) magnet at the National High Magnetic
Field Laboratory (NHMFL) in Tallahassee, Fl. MRI scans were carried out on an ultra-wide bore
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21.1 T (900 MHz) vertical magnet built at the NHMFL. The magnet was equipped with a Bruker
Avance III console and data acquisition was performed with ParaVision 6.0.1 acquisition and
processing (BioSpenCorp, Billerca, MA) software together with a 64 mm inner diameter high
performance gradient (Resonance Research Inc, MA) capable of producing 0.6 T/m peak
gradient strength. Different configurations and dilutions of the QDs were placed in 5-mm NMR
tubes and 8 tubes at a time were imaged using a 33 mm home-built radio frequency (RF) coil. A
Gd contrast agent gadodiamide (Omniscan™) and water were added as controls. All
measurements were acquired with 2D axial orientation with a 150 x150 m in-plane resolution
and 1.5 mm slice thickness. For T1 measurements, a turbo spin echo (SE) sequence was used.
The echo time (TE) was 20 ms and incremented repetition times (TR) between 0.034-1.2s. T2
relaxation were acquired with a multi slice multi echo (MSME) sequence using TR = 5,000 ms
and incremented echo time (4.5 – 90ms). Regions of interest were placed within each tube and
signal intensity data collected. Data were then fitted to an exponential rise to maximum (T 1) and
exponential decay (T2) functions using Matlab.
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CHAPTER 3: RESULTS AND CONCLUSIONS

3.1 QD Synthesis
For the synthesis of all QD samples, hot injection synthesis was used. This method starts
a burst of nucleation that then proceeds to the growth stage by rapidly injecting cooler precursors
into the hot reaction mixture. In order to exclude any atmospheric water that may contribute to
surface defects in the QDs, as well as affecting the hygroscopic precursor salts, the reaction must
take place under an inert atmosphere. To achieve this, a vacuum was attached to the reaction set
up and used to evacuate the system before subsequently flooding it with argon gas. A bubbler
was added between the reaction set up and the vacuum as well as at the top exit vent for the inert
gas. Five different samples were synthesized for this work using varying amounts of GdCl3,
named based off the mmol of Gd used in the reaction: non-doped InP/ZnS, Gd:InP/ZnS (0.224
mmol), Gd:InP/ZnS (0.336 mmol), Gd:InP/ZnS (0.448 mmol), and shell-doped Gd:InP/ZnS
(0.224 mmol) QDs.
In order to ensure the synthesis proceeded as expected, several defining steps in the
reaction were studied (Figure 9). Firstly, as TDMAP was injected, the success of core formation
was assessed on the color change that occured. The reaction mixture started as a pale yellowwhite color, but post-injection, began to darken, ultimately becoming a dark brown. Next, as
dodecanethiol was added to begin shell passivation, successful shelling was assessed via UV
radiation on the reaction mixture. If fluorescence is observed, the shelling process is likely
proceeding, since InP cores are not inherently fluorescent. With every individual synthesis,
samples appeared various shades of dark red under ambient light; however, when irradiated with
UV light, the emitted fluorescent colors were more easily differentiated (Figure 10).

22

A

B

D

C

Figure 9: Appearance of QD synthesis under ambient light or UV light during core synthesis and
shelling. A: Photo of QD synthesis under ambient light before injection of TDMAP. B: Photo of
reaction mixture under ambient light after TDMAP injection and core formation. C: The reaction
mixture following dodecanethiol injection as the mixture appears redder in ambient light. D: The
final product of QDs with UV light to show fluorescence and a successful synthesis.
Post-synthesis, samples were cleaned by adding hexanes to the mixture and centrifuging.
As the QDs are soluble in hexanes, this step was meant to remove oleylamine and any excess
precursor chemicals. It was noticed that for samples Gd:InP/ZnS (0.336 mmol), Gd:InP/ZnS
(0.448 mmol), and shell-doped Gd:InP/ZnS (0.224 mmol) QDs that some of the QDs fell out of
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suspension and became part of the pellet. It is possible that the incorporation of Gd into these
samples led to an unstable crystal structure and a decrease in surface ligands, and ultimately,
resulted in the QDs inability to remain in solution. After this step, all samples were washed twice
with a solution of 70% methanol: 30% chloroform. If the QDs are washed more than this, it can
potentially remove ligands from the surface of the QDs, making them unstable in organic
solvent.
3.2 Water Solubilization of QDs
To impart biological relevance, it is imperative to transfer QDs from the organic solvent
in synthesis into aqueous solution. This was achieved by exchanging the native dodecanethiol
ligands present after synthesis with 11-mercaptoundecanoic acid (MUA), an amphiphilic
molecule that can bind to the surface of the QD and has a terminal hydrophilic carboxylate
moiety. The amount of MUA added was in excess of the amount theoretically needed to ensure
the highest yield of water-soluble product possible. The success of this method was assessed by
centrifuging (~5,000 x g) the emulsion to separate the organic and aqueous layers. The QDs were
observed to move from the organic layer on the bottom to the aqueous layer on top, which can be
checked by UV light (Figure 11). When each sample was centrifuged, 3 layers typically were
seen: the top aqueous layer, a middle layer in between the two phases where some QDs could be
seen that weren’t fully water-soluble, and the bottom organic layer. Occasionally, the bottom
organic layer evaporated overnight, decreasing the visibility of an organic layer. To remove any
aggregates and move samples into a buffer, all samples were dialyzed and subsequently put
through a syringe filter. Samples were then stored at 4C and observed to be stable for many
months. If a sample is not stable, a pellet will form in the bottom of the centrifuge tube.
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InP/ZnS

Gd:InP/ZnS
(0.224 mmol)

Gd:InP/ZnS
(0.336 mmol)

Gd:InP/ZnS
(0.448 mmol)

Gd:InP/ZnS
shell-doped

Gd:InP/ZnS
(0.224 mmol)

Gd:InP/ZnS
(0.336 mmol)

Gd:InP/ZnS
(0.448 mmol)

Gd:InP/ZnS
shell-doped

B

InP/ZnS

Figure 10: Synthesized QD samples under ambient and UV light. A: A diluted sample from each
QD synthesis is shown as it appeared under ambient light. B: Each diluted sample is shown as it
appeared to the eye under UV light.
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3.3 Absorbance and Fluorescence Spectroscopy
As a starting place for characterization, absorbance and fluorescence spectra were
collected for all the samples. Using the absorbance spectra, the size and concentration of QDs
were determined. In order to get the data points for calculations, the maximum wavelength at the
shoulder and the corresponding wavelength were taken. By calculating the particle size via
calculations produced by previous studies38, the extinction coefficient was also determined, and
subsequently, the concentration. The fluorescence emission spectra showed a relative size
distribution of QDs in a sample via its full-width half maximum (FWHM). This gave a relative
particle size distribution as well as showed potential spectroscopic characteristics indicating QD
defects38. Defects in the surface of the nanocrystal creates traps, or nonradiative recombination
sites, causing weak fluorescence.

A

C

B

Figure 11: Stages of water solubilization. A: Before QDs were solubilized, they were on the
bottom layer in the organic phase, with the TMAH-MUA mix on top. B: QDs were placed on a
stir plate with a stir bar to create an emulsion between the two phases. C: After centrifugation the
QDs can be seen in the top layer. The middle layer usually seen prevails in this picture, likely
due to evaporation by the organic layer during solubilization.
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The syntheses performed here produced QDs ranging from ~3-3.6 nm, calculated based
on absorption data collected for each sample (Figure 12). The particle sizes calculated via UVVis spectra can be correlated with color of the QD, further confirmed through the fluorescence
emission spectra (Figure 13). From largest to smallest particle size, the QD samples are
Gd:InP/ZnS (0.448 mmol), InP/ZnS, Shell-doped Gd:InP/ZnS, Gd:InP/ZnS (0.336 mmol), and
Gd:InP/ZnS (0.224 mmol). This same trend is followed in the fluorescence data with the largest

Figure 12: QD particle size. In the samples with 0.224 mmol and 0.336 mmol Gd added to the
reaction, there appears to be a slight decrease in particle size. It is possible that during the
synthesis water was present in the system inhibiting growth, leading to the change in size seen
here39.
QD being the most red shifted, and the smallest shifted more toward the blue. No particular
trend was found in respect to concentration, though all core-doped samples had a higher
concentration than both the non-doped and shell-doped, which were fairly similar. The highest
concentration sample was that of Gd:InP/ZnS (0.336 mmol) that was calculated to be 56.5 M,
much higher than any of the others. Gd:InP/ZnS (0.224 mmol) and (0.336 mmol) had
concentrations 13 M and 22 M respectively while both non-doped and shell-doped QDs came
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to around 8 M. To note, calculations for Gd-doped dots were not verified due to the complexity
of the calculations, and thus by using the calculations for non-doped dots, error may have been
introduced. Due to the difference in atomic radii size between In and Gd, and the assumption Gd
is replacing In, the larger radii from Gd could be skewing the calculations somewhat, giving an
artificially higher concentration.

Figure 13: UV-Vis Absorption Spectra of non-doped and Gd-doped InP/ZnS QDs. UV-vis
spectra of QD samples were collected, and the maximum of the shoulder was used to calculate
average particle size and final concentration of the synthesized sample.
From the stock concentrations, each QD product was diluted to ~1 M and the
fluorescence spectra were obtained. These spectra were analyzed to discern the overall size
distribution of QD nanoparticles (Figure 14). Addition of Gd did not seem to have an appreciable
effect on size distribution. Non-doped QDs and Gd:InP/ZnS (0.0224 mmol) both had similar
FWHM at around 62 nm. Gd:InP/ZnS (0.336 mmol) measured with a FWHM around 75 nm,
Gd:InP/ZnS (0.448 mmol) around 68 nm, and shell-doped Gd:InP/ZnS around 71 nm.
Commercially available InP/ZnS QDs with low size distributions exhibit a FWHM below 70
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nm10,40. Thus, it does not appear that incorporation of Gd had an effect on particle size. However,
this larger size distribution is potentially due to the fact that these reactions were scaled-up to
produce sufficient QD products for the characterization herein. It is possible that increasing the
scale of these reactions affected the reaction kinetics. Future work on this project may attempt to
optimize size distribution of QD products at this scale. Additionally while observed by eye that
the Gd:InP/ZnS (0.448 mmol) sample is more red-shifted than that of undoped InP/ZnS, both
samples share a close lambda maximum for emitted wavelengths. The differences in these
observations are likely due to the overlap in size distributions of the particles, with the majority
of QDs synthesized with less Gd slightly blue-shifted.

Figure 14: Fluorescence Emission Spectra of non-doped and Gd-doped InP/ZnS QDs.
Fluorescence spectra of QDs show the relative size distribution of QDs in solution. As the QD
size increases, the spectra become more red-shifted.

3.4 Scanning Transmission Electron Microscopy
Following synthesis, samples of different QDs were sent for Scanning Transmission
Electron Microscopy (STEM) analysis at Jordon Valley Innovation Center (JVIC) (Springfield,
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MO) to assess the size and shape dispersity of the nanoparticles. Non-aggregated, monodisperse
particles are important for biological studies due to the unpredictability of aggregates. Nondoped InP/ZnS, Gd:InP/ZnS (0.224 mmol), and Gd:InP/ZnS (0.336 mmol) were imaged in this
study (Figure 15). Non-doped QDs demonstrate some aggregation in the micrographs with
clusters of 7-8 QDs closely bunched together throughout the image. It is possible, while diluting

A

B

C

Figure 15: STEM micrographs demonstrating monodispersity of QDs. STEM images of nondoped and Gd-doped InP/ZnS QDs showing the monodispersity of (a) InP/ZnS QDs, (b)
Gd:InP/ZnS (0.224 mmol), and (c) Gd:InP/ZnS (0.448 mmol) QDs. For each image, an insert
shows a zoomed in area of the displayed image. A scale bar for the insert was calculated and
generated based on the size of each pixel in the image.
this sample to a sufficient concentration for imaging, the sample could have become unstable.
Previous observations in our lab have shown that samples are not stable at very low
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concentrations. Regardless, individual QDs appeared monodisperse in size and shape. Gd-doped
samples appeared clearly monodisperse and can be easily differentiated from each other,
demonstrating that incorporation of Gd at the amounts used in these syntheses does not have an
appreciable effect on the shape or size of the nanoparticles. Analysis of the micrographs showed
the samples have a size of ~3.5 nm, which closely matched with the estimated size of the
InP/ZnS QDs through calculations (Figure 12). While it would be interesting to see the STEM
imaging results for Gd:InP/ZnS (0.448 mmol) and shell-doped Gd:InP/ZnS QD samples,
research limitations prevented collection of this data.

3.5 Elemental Analysis via Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
In order to determine the amount of Gd incorporated into the QDs and the elemental
composition of the nanoparticles, ICP-MS was performed. Three separate ICP-MS analyses were
performed for each sample (Figure 16). The ratio of Zn to S is less than one for all QD samples
analyzed, indicating an abundance of sulfur. However, this is likely attributed to the presence of
S in the dodecanethiol ligand coating the exterior of the QD. Additionally, this analysis reveals
that an increased amount of Gd in the reaction corresponded to an increase in the amount of Gd
incorporated into the QD. However, the ratio of Gd/In does not increase at the same molar ratio
at which it is incorporated, which is may be due to the kinetics of the reaction and presents
opportunities for future work in this area. Further, results indicated a discrepancy in the ratio of
Gd and In to P. The expected ratio would be 1:1; however for Gd:InP/ZnS (0.224 mmol) the
ratio was 1.56. This observation could be an indication of oxidation, with a decrease in P being
seen as a result.

31

Figure 16: Elemental analysis of QD samples analyzed via ICP-MS. Using ICP, the molar ratios
of Zn:S, (In+Gd):P, and Gd:In were found. This was used to determine the success of the
synthesis as well as the amount of Gd incorporated into the QDs.
3.6 MRI Contrasting Capabilities
In order to investigate MRI capabilities of the QDs, water-solubilized QD samples were
sent to Dr. Jens Rosenberg at the National High Magnetic Field Lab (Tallahassee, Florida).
Three concentrations (1M, 500 nM, and 100 nM) of QD solution were analyzed. While
nanomolar concentrations are relevant in in vivo application of QDs, a concentration of 1 M
was also used since it is most likely to have visible contrast41,42. For each sample, both T1 and T2
relaxation data was gathered.
For the samples sent for characterization, the image maps generated for T1 and T2
relaxation were compared to a conventional contrasting agent used in clinical MRI, gadodiamide
(Omniscan™). When the analysis was performed, the data for the top and bottom rows of Figure
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17 were taken separately from each other. Samples in the top row (dissolved in a PBS) appeared
brighter because the software scaled the image to the brightest voxel. In the top row, the brightest
voxel was from water, making the samples appear bright, though their relaxation time was not
actually considerably short (Figure 17, Figure 18). For the bottom row of samples and the PBS
control, however, samples were scaled to gadodiamide. In T1 contrast if the relaxation time is
short, one would expect a bright contrast. The samples in the bottom row of Figure 17 appear

Figure 17: Mapped T1 relaxation times for QD samples. Samples were measured in an NMR
with a 21.1 Tesla magnet fitted with an imaging probe. Pixels in the top row were scaled to the
brightest pixel of the water sample, while pixels in the bottom row were scaled to the brightest
pixel of the Omniscan sample.
darker than the top row because the samples on the bottom row were scaled to gadodiamide
(with a very low T1 of 15.9 ms). When comparing both the images and relaxation times, a
modest increase in brightness in the samples can be seen, especially when compared with the
PBS control. Additionally there is a modest decrease in relaxation time for the more concentrated
samples of Gd:InP/ZnS (0.448 mmol) and shell-doped Gd:InP/ZnS QDs. While a relatively small
amount of Gd was added to the shell-doped sample (0.224 mmol), the relaxation displayed by
the shell-doped sample is much more comparable to a higher doped sample. This is likely a
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Figure 18: Average T1 relaxation times for QDs. While modest, Gd:InP/ZnS (0.448 mmol) and
shell-doped Gd:InP/ZnS QDs at higher concentrations show a decrease in T1 time compared to
PBS.
result of the Gd being closer to the surface of the QD, and as a result, causing a more noticeable
relaxation in the nearby water molecules. However, the relaxation times for these QD samples
were around 2200 ms and above; since promising contrast agents are typically below 1000 ms,
T1 contrast does not appear to be a suitable modality for these QDs43.
Gd-doped QDs show a more prominent potential as a T2 contrast agent. All images in
Figure 19 were scaled to gadodiamide, which has a T2 time too short for it to be visually
noticeable. Both Gd:InP/ZnS (0.448 mmol) and shell-doped QD images are visibly darker than
that of the PBS control or undoped QD images.. Additionally, these samples demonstrate a clear
reduction in relaxation times compared to the PBS control (Figure 20). T2 relaxation for the PBS
control was around 400 ms, while samples from both the Gd:InP/ZnS (0.448 mmol) and shell-
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doped Gd:InP/ZnS samples had relaxation times around 100-140 ms and 180-190 ms
respectively in the 1 M and 500 nM concentrations. The typical contrast agent has a T2

Figure 19: Mapped T2 relaxation times for QD samples. Samples were measured in an NMR
with a 21.1 Tesla magnet fitted with an imaging probe and scaled to Omniscan. The Omniscan
T2 relaxation was much shorter than the samples, which caused it to be too dark to appear.
relaxation of 100 ms or lower43. As with T1, the shell-doped sample shows improved contrast,
similar to Gd:InP/ZnS (0.448 mmol). The Gd in this sample, however, was closer to the surface
of the QD, thus closer to the aqueous solvent and likely allowing a larger effect on water
molecules. Comparatively, the contrast seen in the QD samples was modest compared with
gadodiamide, which has a relaxation around 9.3 ms.

3.7 MTT Cell Viability Assay
In order for Gd-doped QDs to be a feasible diagnostic tool, the cytotoxicity must be
examined. Here, toxicity was studied using an MTT assay, which uses cellular respiration as a
baseline for viability. A wide range of QD concentrations were used to assess cellular viability.
QD concentrations of 100 nM- 500 nM were chosen to assess the viability in the concentration
range that contrast data is often acquired41. Additionally, lower concentrations (250 pM- 1 nM)
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were chosen to assess viability in the concentration range that is typically used for cellular
labeling41.

Figure 20: Average T2 relaxation times for QDs. For both Gd:InP/ZnS (0.448 mmol) and shelldoped Gd:InP/ZnS QDs, there was a noticeable decrease in T2 relaxation when compared against
the control, presenting potential for use as an MRI contrasting agent.
A decrease in viability was observed in cells treated with higher concentration of the QD
samples, especially for shell-doped Gd:InP/ZnS (Figure 21). For the cells treated with 250 pM –
1nM QDs, the cell viability remains above 80%. However, a trend can be seen that with
increased Gd content, there is a decrease in cell viability. For higher concentrations (100 nM500 nM), cell viability decreased in both non-doped and shell-doped samples. In the case of the
non-doped samples, it is possible that at this concentration particles begin to aggregate onto the
cells, resulting in toxicity. STEM micrographs indicate that this sample was more prone to
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aggregation (Figure 3.7). For shell-doped QDs, Gd was closer to the surface of the QD;
therefore, Gd is more likely to be released into the surrounding medium. At 250 nM and 500 nM,
QDs with the highest Gd content (0.448 mmol) cause a decrease in cell viability below 80 %.
While higher concentrations of QDs show cytotoxicity, these concentrations are not typically
used in cellular labeling applications41. QD concentrations usually used for cell targeting show
little effect on cell viability.

Figure 21: MTT Viability Assay for non-doped and Gd-doped InP/ZnS QDs. For most samples
cellular viability does not decline below 80 % until 100 nM and above. However, for labeling,
cells are usually not treated with concentrations over 100 nM QDs.
3.9 Conclusions and Future Work
This work represents a preliminary study of newly-synthesized Gd-doped QDs and their
utility as an MRI contrast agent. Through absorbance data, particle size and concentration were
calculated for each sample. The particle size was then compared to the lambda max of each
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fluorescence spectrum. Furthermore, the fluorescence spectra FWHM were analyzed for the size
distribution of the nanoparticles and potential contamination by water during synthesis. Particle
size via STEM data was correlated to particle size via absorbance calculations and found to be in
relative agreement (Figure 12). ICP-MS data demonstrated that the ratio of (Gd+In):P was higher
than expected for Gd:InP/ZnS (0.224 mmol) and Gd:InP/ZnS (0.336 nmol) suggesting that
oxygen may have been incorporated into the crystal lattice in place of P (Figure 16). Both of
these samples have a smaller average size than the rest of the samples which is also indicative of
oxidation (Figure 12). Assessing the samples for MRI contrast showed moderate imaging
capabilities of Gd:InP/ZnS (0.448 mmol) and shell-doped QDs. While the contrast for T1 was
minimal, T2 presented much better contrast for these samples. When assessing the toxicity of the
QD samples, Gd-doped QDs do not appear to have a negative impact on cell viability within
concentrations used for normal cellular labeling.
Future work could investigate using Manganese2+ as the shell-doping agent, due to its
biocompatibility and paramagnetism. Additionally, samples could be PEGylated to assess the
MRI capabilities, since it is expected that the highly hydrophilic nature of PEG may bring water
molecules closer to the QD surface, and thus paramagnetic ions. As seen in the results, it is
possible the kinetics of the original synthesis reaction were affected when the synthesis was
scaled up, which could also be further optimized. Additionally, there is potential that more Gd
could be incorporated into the crystal structure. More syntheses could be performed with
increased mmol amounts of Gd until potentially QDs are unable to be formed. This work
provides many potential avenues for further development and optimization for an MRI-active
QD.
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